CIK: 0001232621 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value ($000): $612,464 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 13,796,747 | $267,795 | 43.7% | $24.38 | — | COM | 676079106 |
| HRTX | HERON THERAPEUTICS INC | 5,950,826 | $188,343 | 30.8% | $14.10 | +164.2% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 4,138,893 | $83,316 | 13.6% | $18.53 | — | COM | 503459604 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $73,010 | 11.9% | $16.31 | +33.0% | COM | 77313F106 |